Delivery Order SPE2DB22D2206-SPE2DB24FEL04
- Not listed
- This federal contract award is for the delivery of Teriparatide 620 mcg/2.48 ml medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,598.99 and an ultimate completion date of December 28, 2023. The contract was awarded on December 27, 2023 and is not designated as a set-aside....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide teriparatide 620 mcg/2.48 ml 2.48 ml. The contract has a ceiling value of $8,334.95 and a period of performance through January 6, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 620 mcg/2.48 ml vials of the drug teriparatide. The contract is a firm fixed-price delivery order with a ceiling value of $16,819.13 and a period of performance through May 19, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside. The company also holds a larger $999,999,999.00 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is a delivery order (SPE2DB20D3101|SPE2DB24FRUX6) for the pharmaceutical product Teriparatide 620 mcg/2.48 ml, 2.48 ml. The contract has a firm fixed price of $4,273.08 and an ultimate completion date of September 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing this product under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a delivery order with a firm fixed price of $3,312.71 and a performance period extending through May 14, 2025. The contract is for the supply of 4568239280 - TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, a medication used to treat certain types of osteoporosis. The contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,754.28, is for the delivery of teriparatide 600 mcg/2.4 ml pens. This is a firm fixed-price delivery order contract with an ultimate completion date of March 4, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,322.27 firm fixed-price delivery order is for the supply of 560mcg/2.24ml pens of the drug teriparatide, a medication used to treat osteoporosis. The contract has an ultimate completion date of June 18, 2025 and does not have a set-aside designation, indicating open competition....
- This contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed-price delivery order, valued at $2,543.49, is for the supply of 4,565,891.733 milliliters of the prescription medication teriparatide 600 micrograms per 2.4 milliliters. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,459.30 firm fixed-price delivery order is for the supply of Teriparatide 620 mcg/2.48 ml, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical....
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEL04Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Teriparatide 620 mcg/2.48 ml 2.48 ml. The contract, valued at $6,403.31, is a delivery order with a firm fixed price. The contract has an ultimate completion date of December 4, 2023 and was awarded on December 1, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. Cencora, Inc. holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a specific delivery order under that larger IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 12/1/23 |